Explore pivotal results and announcements from cancer studies and trials with focus on Head and Neck Studies. Uncover FDA updates…
Day: January 24, 2026
Serplulimab Wins UK Approval Among Other Cancer Treatment Advances
In-depth report on latest updates in cancer treatments, including UKs approval of Serplulimab and challenges in managing immune-checkpoint inhibitor side-effects.